MDWD - MediWound Ltd
IEX Last Trade
18.33
0.100 0.546%
Share volume: 49,928
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.23
0.10
0.55%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-15 | 2023-03-16 | 2023-05-30 | 2023-08-15 | 2023-11-21 | 2024-03-21 | 2024-05-29 | |
| Assets | |||||||||
| Total Assets | 21.106 M | 28.585 M | 50.016 M | 68.666 M | 64.366 M | 67.017 M | 66.459 M | 62.377 M | |
| Current Assets | 16.809 M | 24.448 M | 45.840 M | 63.271 M | 58.053 M | 53.250 M | 49.695 M | 44.196 M | |
| Inventories | 1.991 M | 1.880 M | 1.963 M | 2.536 M | 3.113 M | 3.656 M | 2.846 M | 3.311 M | |
| Other Current Assets | 0.000 | 0.000 | 650.000 K | 0.000 | 0.000 | 0.000 | 1.044 M | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 650.000 K | 0.000 | 0.000 | 0.000 | 1.044 M | 0.000 | |
| Total Receivables | 4.412 M | 4.976 M | 9.332 M | 3.531 M | 3.818 M | 4.071 M | 4.097 M | 5.317 M | |
| Current Cash | 10.406 M | 17.592 M | 33.895 M | 57.204 M | 51.122 M | 45.523 M | 41.541 M | 35.568 M | |
| Total Non-current Assets | 4.297 M | 4.137 M | 4.176 M | 5.395 M | 6.313 M | 13.767 M | 16.764 M | 18.181 M | |
| Property Plant Equipment | 2.439 M | 2.354 M | 2.366 M | 3.724 M | 4.705 M | 6.437 M | 9.228 M | 10.422 M | |
| Other Assets | 230.000 K | 230.000 K | 364.000 K | 305.000 K | 277.000 K | 483.000 K | 233.000 K | 238.000 K | |
| Intangible Assets | 264.000 K | 248.000 K | 231.000 K | 215.000 K | 198.000 K | 182.000 K | 165.000 K | 149.000 K | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 21.106 M | 28.585 M | 50.016 M | 68.666 M | 64.366 M | 67.017 M | 66.459 M | 62.377 M | |
| Total liabilities | 23.341 M | 26.929 M | 39.102 M | 35.366 M | 29.437 M | 33.967 M | 34.864 M | 39.178 M | |
| Total current liabilities | 10.416 M | 9.012 M | 12.057 M | 9.264 M | 8.309 M | 8.441 M | 10.829 M | 16.840 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 11.872 M | 16.965 M | 26.199 M | 25.359 M | 20.451 M | 19.591 M | 17.685 M | 22.338 M | |
| Current long term debt | 2.479 M | 2.461 M | 2.242 M | 2.139 M | 1.961 M | 1.692 M | 1.410 M | 6.467 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 11.872 M | 16.965 M | 26.199 M | 25.359 M | 20.451 M | 19.591 M | 17.685 M | 22.338 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -2.235 M | 1.656 M | 10.914 M | 33.300 M | 34.929 M | 33.050 M | 31.595 M | 23.199 M | |
| Common stock | 33.140 M | 4.783 M | 6.326 M | 8.388 M | 9.209 M | 9.217 M | 9.239 M | 9.234 M | |
| Retained earnings | 0.000 | 0.000 | -168.106 M | 0.000 | -170.883 M | 0.000 | -174.822 M | 0.000 |